(Q39100496)

9 September 2017

title

A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity (English)

1 reference

9 September 2017

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Shane A Olwill

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Christian Joffroy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Hendrik Gille

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Elisa Vigna

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Gabriele Matschiner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Andrea Allersdorfer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Bradley M Lunde

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jakub Jaworski

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

James F Burrows

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Cristina Chiriaco

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Hans Jürgen Christian

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Martin Hülsmeyer

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Stefan Trentmann

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Andreas M Hohlbaum

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Laurent Audoly

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

3 September 2013

1 reference

Molecular Cancer Therapeutics

9 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

2459-2471

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24002935%20AND%20SRC:MED&resulttype=core&format=json